Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Bill Gates announces $50 million investment to fight Alzheimer’s Disease

_____

Why I’m Dig­ging Deep Into Alzheimer’s (Bill Gates):

In every part of the world, peo­ple are liv­ing longer than they used to. Thanks to sci­en­tif­ic advance­ments, few­er peo­ple die young from heart dis­ease, can­cer, and infec­tious dis­eases. It’s no longer unusu­al for a per­son to live well into their 80s and beyond. My dad will cel­e­brate his 92nd birth­day in a cou­ple weeks, a mile­stone that was prac­ti­cal­ly unimag­in­able when he was born.

This fact—that peo­ple are liv­ing longer than ever before—should always be a won­der­ful thing. But what hap­pens when it’s not? Read the rest of this entry »

Augmenting physiotherapy via neurofeedback and neurostimulation: Key neurotechnology patent #43

therapy control

– Illus­tra­tive image from U.S. Patent No. 8,121,694

Today we are shar­ing a fas­ci­nat­ing patent from Medtron­ic.  (As men­tioned, we are fea­tur­ing 50 foun­da­tion­al Per­va­sive Neu­rotech patents, from old­er to new­er by issue date)

U.S. Patent No. 8,121,694: Therapy control based on a patient movement state

  • Assignee(s): Medtron­ic, Inc.
  • Inventor(s): Gre­go­ry F. Mol­nar, Steven S. Gill, Kei­th A, Miesel, Mark S. Lent, Tim­o­thy J. Deni­son, Eric J. Panken, Carl D. Wahlstrand, Jonathan C. Werder
  • Tech­nol­o­gy Cat­e­go­ry: Neu­ro-mon­i­tor­ing
  • Issue Date: Feb­ru­ary 21, 2012

SharpBrains’ Take:

The ‘694 patent dis­clos­es meth­ods to treat patients afflict­ed with move­ment or oth­er neu­rode­gen­er­a­tive dis­or­ders through brain-sig­nal feed­back. Read the rest of this entry »

Study debunks 4 common myths about brain training and lifelong cognitive enhancement

If the media is your main source of infor­ma­tion about brain train­ing and cog­ni­tive enhance­ment, you will prob­a­bly believe the fol­low­ing:

1) All brain train­ing is the same…

2) …and it sim­ply doesn’t work.

3) Com­mer­cial brain train­ing pro­grams, espe­cial­ly, don’t work.

4) How could they work? Genet­ics is des­tiny, aging is a pre­de­ter­mined process…so by age 60 or 70 or 80, “you can’t teach an old dog new tricks.”

If you tracked and ana­lyzed the sci­en­tif­ic lit­er­a­ture around cog­ni­tive train­ing, cog­ni­tive ther­a­pies, biofeed­back, med­i­ta­tion, brain reserve and neu­ro­plas­tic­i­ty in gen­er­al, you’d know those 4 beliefs are wrong. They are myths that pre­vent a more nuanced con­ver­sa­tion about brain-enhanc­ing lifestyles and about the emerg­ing brain train­ing and neu­rotech­nol­o­gy toolk­it.

Good news is, a just-pub­lished study should help debunk those myths–especially with regards to com­put­er­ized cog­ni­tive training–and pro­vide a bet­ter Read the rest of this entry »

News: Advanced Brain Monitoring receives Global Health and Pharma Award for clinical-grade platforms monitoring brain’s electrical activity

Advanced Brain Mon­i­tor­ing Named “Most Inno­v­a­tive Med­ical Device Com­pa­ny” at Glob­al Health and Phar­ma Awards (Sleep Review):

Advanced Brain Mon­i­tor­ing Inc was named the “Most Inno­v­a­tive Med­ical Device Com­pa­ny” by Glob­al Health and Phar­ma at its 2016 Health­care and Phar­ma­ceu­ti­cal awards. “This award rec­og­nizes our company’s suc­cess­es in devel­op­ing tech­nolo­gies which enable clin­i­cians and clin­i­cal tri­al spon­sors to pro­file brain health through the analy­sis of the brain’s elec­tri­cal activ­i­ty (EEG) dur­ing sleep and wake,” says Chris Berka, Advanced Brain Mon­i­tor­ing CEO…The com­pa­ny was recent­ly award­ed a $1.5 mm grant from Nation­al Insti­tute of Health to expand its data­base of awake and sleep EEG in patients with neu­rode­gen­er­a­tive dis­eases. “The envi­sioned future is for rou­tine brain health assess­ments dur­ing sleep and wak­ing to be con­duct­ed in a man­ner sim­i­lar to a mam­mo­gram or colonoscopy,” says Berka. “Ulti­mate­ly, ear­ly detec­tion will increase the like­li­hood that an inter­ven­tion can be matched to the patient based on the pres­ence of brain bio­mark­ers and admin­is­tered pri­or to the onset of cog­ni­tive decline.”

To learn more:

Dr. Michael Merzenich: To harness Neuroplasticity for cognitive enhancement, we need to think “Fitness” more than “Games”

KavliPrize-Neuro(Editor’s Note: In order to help read­ers famil­iar­ize them­selves with the work and think­ing of Dr. Michael Merzenich, one of the win­ners of the 2016 Kavli Prize in Neu­ro­science for ground­break­ing work on neu­ro­plas­tic­i­ty, we are con­dens­ing and repub­lish­ing the com­pre­hen­sive con­ver­sa­tion that Dr. Merzenich and Alvaro Fer­nan­dez had in 2009, in prepa­ra­tion for the inau­gur­al Sharp­Brains Vir­tu­al Sum­mit.)

Dr. Michael Merzenich, Emer­i­tus Pro­fes­sor at UCSF, is a lead­ing pio­neer in brain plas­tic­i­ty research. In the late 1980s, Dr. Merzenich was on the team that invent­ed the cochlear implant. In 1996, he was the found­ing CEO of Sci­en­tif­ic Learn­ing Cor­po­ra­tion, and in 2004 became co-founder and Read the rest of this entry »

All Slidedecks & Recordings Available — click image below

Search for anything brain-related in our article archives

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters, and more, SharpBrains is an independent market research firm and think tank tracking health and performance applications of brain science.

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.